Yearly Archives: 2022

Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor

Mirati Therapeutics, in collaboration with Array BioPharma (Pfizer) and Monoceros [...]

By |2022-10-19T17:45:12+00:00October 10th, 2022|News|Comments Off on Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor

Monoceros Biosystems Recognized on Inc. 5000 List of Fastest-Growing Private Companies in America

By |2022-08-22T15:21:57+00:00August 19th, 2022|News|Comments Off on Monoceros Biosystems Recognized on Inc. 5000 List of Fastest-Growing Private Companies in America
Go to Top